Skip to main content
. Author manuscript; available in PMC: 2015 Jan 17.
Published in final edited form as: Nature. 2014 Jul 2;511(7509):312–318. doi: 10.1038/nature13547

Extended Data Figure 1. Screening strategy for identification of minimal set of transcriptions factors (TFs) for reprogramming ECs into hematopoietic cells.

Extended Data Figure 1

A. Candidate genes tested for reprogramming of HUVECs into hematopoietic colonies. To identify TFs that drive EHT transition, we performed RNA-seq of HUVECs and Lin-CD34+ umbilical cord HSPCs to select TFs differentially expressed by HSPCs, but not by HUVECs. We then screened various combinations of differentially expressed TFs to identify a minimal set capable of reprogramming ECs to hematopoietic cells. Levels of expression [log2(RNA-seq value)] in HUVECs and freshly purified CD34+Lin cord blood cells.

B. One-by-one elimination of TFs experiment revealed a minimal set of TFs; FOSB, GFI1, RUNX1, and SPI1, (FGRS) capable of generating hematopoietic colonies in the HUVEC culture. A pulled set of 26 TFs minus one TF was evaluated for the ability to evoke formation of hematopoietic clusters (day 21 to 25; n=3). Asterisks show statistically significant (p<0.05) reduction of the number of hematopoietic clusters in the transduced HUVECs compared to the full set of TFs. Control represents non-transduced HUVECs. Transduced cells were cultured on a layer of serum-free E4EC monolayers.

C. One-by-one elimination of the FGRS factors shows that all four FGRS-TFs are necessary and sufficient for generation of hematopoietic colonies (day21 to 25; n=3).

All” in B and C: all TFs are present. “Control” in B and C: all TFs are absent.

D. Schema for reprogramming of ECs into human multipotent progenitor cells (rEC-hMPPs). Clonal or bulk populations of HUVECs or hDMECs were transduced with the FGRS and after 3 days were replated on subconfluent monolayers of E4EC ECs. The emerging colonies of hematopoietic cells were subjected to 1) multi-variate immunophenotypic analyses, 2) clonal and oligo-clonal CFC assay, and 3) molecular profiling (RNA-seq). Tissues of the engrafted mice were processed for histological examination to rule out any malignant transformation.